Company news
Sparx Group Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Notice of Receipt of Dividend from Consolidated Subsidiary
October 29, 2026
Notice Regarding the Payment of Interim Dividends
October 29, 2026
Notice Regarding Resolution on Acquisition of Treasury Shares and Cancellation of Treasury Shares
October 29, 2026
FY2026 2nd Quarter Earnings Presentation
October 29, 2026
Consolidated Financial Results for the Fiscal Year 2026 (April 2026 - September 2026)
October 29, 2026
SPARX Group Announces Assets Under Management for September 2026
October 7, 2026
SPARX Group Announces Assets Under Management for August 2026
September 7, 2026
SPARX Group Announces Assets Under Management for July 2026
August 7, 2026
FY2026 1st Quarter Earnings Presentation
July 31, 2026
SPARX Group Announces Assets Under Management for June 2026
July 7, 2026
Notice of Receipt of Dividend from Consolidated Subsidiary
June 15, 2026
SPARX Group Announces Assets Under Management for May 2026
June 5, 2026
SPARX Announces Assets Under Management for July 2022
August 5, 2022
Sparx Group: Space Frontier Fund Invests in SpaceData, a Creator and Provider of an Earth Digital Twin Generated from Satellite Data
August 2, 2022
Summary Report of Consolidated Financial Results for the Fiscal Year 2022 (April, 2022 - June, 2022)
July 29, 2022
Notice regarding Disposition of Treasury Stock through Third-Party Allotment with the Introduction of Stock Compensation System
July 29, 2022
Notice on Decision-made Related to Acquiring Share for Stock Compensation System
July 29, 2022
FY2022 1st Quarter Earnings Presentation
July 29, 2022
Sparx Group: Mirai Creation Fund III Invests in Xcoo, a developer of Chrovis, a total solution software for genome and bioinformatics data analyses
July 11, 2022
SPARX Announces Assets Under Management for June 2022
July 7, 2022
Sparx Group: Mirai Creation Fund III (three) Invests in ProteoBridge, a Developer of high-density protein microarrays for autoantibody validation
June 29, 2022
Sparx Group: Mirai Creation Fund III Invests in ArchiTek, an Edge AI Processor Developer
June 20, 2022
SPARX Announces Assets Under Management for May 2022
June 7, 2022
Issuing the First Publicly Offered Digital Retail Bonds Under a Framework from Japanese Corporations
May 30, 2022
Notice of the Winning of the R&I Fund Award 2022
April 26, 2022
SPARX Announces Assets Under Management for March 2022
April 7, 2022
Sparx Group: Mirai Creation Fund III Invests in Nealle, a Developer of Mobility SaaS
April 5, 2022
Notice of Current Status of Alleged Lawsuit Brought Against Our Subsidiary in the U.S.
April 1, 2022
SPARX Announces the Reopening of Its Tokyo Offices
March 31, 2022
Notice Concerning the Selection of the Company’s Stock for Loan Margin Trading on the Tokyo Stock Exchange
March 30, 2022
Sparx Group: Space Frontier Fund Invests in Synspective, a SAR satellite data and solutions provider
March 28, 2022
Sparx Group: Space Frontier Fund Invests in ArkEdge Space, a Builder of Nanosatellite Constellations
March 28, 2022
Sparx Group: Mirai Creation Fund III Invests in EneCoat Technologies, a Firm Aiming to Generate Power Anywhere
March 27, 2022
SPARX Announces Assets Under Management for February 2022
March 7, 2022
Nomura SPARX-Managed Fund Received Additional Investment Commitment
February 22, 2022
SPARX Announces Assets Under Management for January 2022
February 7, 2022
Notice Regarding Revision to an Expected Dividend
January 31, 2022
Decks
- Q2 FY2026 Earnings Presentation
Earnings · 46 slides · Oct 30, 2026
- Q2 FY2027 Earnings Presentation
Earnings · 46 slides · Oct 30, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 42 slides · Jul 31, 2026